head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2020, vol. 26, issue2
Subject Area: Medicine
DOI: 10.5272/jimab.2020262.3092
Published online: 24 April 2020

Original article

J of IMAB. 2020 Apr-Jun;26(2):3092-3097
Erna IslamagicORCID logo Corresponding Autoremail, Amra LisovacORCID logo, Muhamed FocakORCID logo, Damir SuljevicORCID logo,
Department of Biochemistry and Physiology, Faculty of Science, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Purpose: The aim of this study was to analyze the predictive potential of selected biochemical and hematological parameters in patients with gout from Bosnia and Herzegovina, and to determine the most common comorbidities related to gout.
Methods: Forty patients with gout (17 males and 23 females) from the hospital in the municipality of Novi Grad, Sarajevo were included in the present study. We analyzed biochemical parameters (uric acid, urea, creatinine, and CRP), ESR, and WBC as a hematological parameter. The Shapiro-Wilk test and the Spearman correlation coefficient were used for the normality and correlation analysis, respectively.               
Results: Most gout patients were 50-70 years old and gout was more prevalent in female patients. Thirteen different comorbidities are related to gout. After the onset of the main disease, 82.35% of male patients were diagnosed with cardiovascular disease, while hypertension was diagnosed in 76.47% of male patients. High mean values of ESR, as well as CRP, uric acid, urea, and creatinine concentrations were found for all gout patients. A strong positive correlation was found after comparing urea and ESR (ρ=0.314); urea and creatinine (ρ=0.526); CRP and ESR (ρ=0.375).
Conclusion: We can conclude that the analyzed biochemical parameters, CRP, urea, creatinine, and uric acid, as well as ESR, are good predictors of gout. High values of uric acid, creatinine, and urea are the most important gout predictors and significant markers for the development of comorbidities.

Keywords: gout, comorbidities, ESR, WBC, CRP, urea, creatinine, uric acid,

pdf - Download FULL TEXT /PDF 1167 KB/
Please cite this article as: Islamagic E, Lisovac A, Focak M, Suljevic D. Comorbidity and gout: association between hyperuricemia and blood parameters as a predictor of gout. J of IMAB. 2020 Apr-Jun;26(2):3092-3097. DOI: 10.5272/jimab.2020262.3092

Corresponding AutorCorrespondence to: Erna Islamagic, MA, Faculty of Science, University of Sarajevo; Zmaja od Bosne 33-35, 71000 Sarajevo, Bosnia and Herzegovina; E-mail: erna.islamagic@hotmail.com

1. Mikuls T,  Farrar J,  Bilker W, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK general practice research database, 1990-1999. Ann Rheum Dis. 2005 Feb;64:267-72. [PubMed] [Crossref]
2. Ruggiero C, Cherubini A, Ble A, Bos A, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. Eur Heart J. 2006 May; 27(10): 1174–81. [PubMed] [Crossref]
3. Xiang LW, Li J, Lin JM, Li HF. Determination of gouty arthritis' biomarkers in human urine using reversed-phase high-performance liquid chromatography. J Pharm Anal. 2014 Apr;4(2):153-8. [PubMed] [Crossref]
4. Rosa Neto NS, de Carvalho JF. [The use of inflammatory laboratory tests in rheumatology.] [In Portuguese] Rev Bras Reumatol. 2009 July-Aug;49(4). [Crossref]
5. Tagoe CE, Raza Y. Differences in Acute Phase Reactants between Gout and Pseudogout. Int J Clin Med. 2013 Jan; 4: 13-9. [Crossref]
6. Lee JH, Yang JA, Shin K, Lee GH, Lee WW, Lee EY, et al. Elderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks. J Korean Med Sci. 2017 Dec; 32(12): 1967-73. [PubMed] [Crossref]
7. ter Borg E, Wegewijs MA, de Bruin P. Gout and AA Amyloidosis: A Case Report and Review of the Literature. J Clin Rheumatol. 2017 Jun; 23(4): 233–4. [PubMed] [Crossref]
8. Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. 2015 Apr; 74(4): 642–7. [PubMed] [Crossref]
9. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007 Feb; 57(1): 109–15. [PubMed] [Crossref]
10. Kim S,  Guevara J, Kim K, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Care Res. 2009 Jul; 61: 885-92. [PubMed] [Crossref]
11. Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels-the Third National Health and Nutrition Examination Survey. Rheumatology. 2008 May; 47: 713-7. [PubMed] [Crossref]
12. Singh JA. The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout. Arthritis Res Ther. 2014 Jun; 16(3): R132. [PubMed] [Crossref]
13. Stamp LK, Chapman PT. Gout and its comorbidities: implications for therapy. Rheumatology (Oxford). 2013 Jan; 52(1): 34-44. [PubMed] [Crossref]
14. Janssens HJ, Fransen J, van de Lisdonk EH, van Riel PL, van Weel C, Janssen M. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med. 2010 Jul; 170(13): 1120-6. [PubMed] [Crossref]
15. Bernal JA, Quilis N, Andrés M, Sivera F, Pascual E. Gout: optimizing treatment to achieve a disease cure. Ther Adv Chronic Dis. 2016 Mar; 7(2): 135–44. [PubMed] [Crossref]
16. McAdams-DeMarco MA, Maynard JW, Coresh J, Baer AN. Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study. Arthritis Res Ther. 2012 Aug;14(4):R193. [PubMed] [Crossref]
17. Veronese N, Carraro S, Bano G, Trevisan C, Solmi M, Luchini C, et al. Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur J Clin Invest. 2016 Nov; 46(11): 920–30. [PubMed] [Crossref]
18. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011 Oct; 63(10): 3136–41. [PubMed] [Crossref]
19. Chen L, Peng Y, Fang F, Chen J, Pan L, You L. Correlation of serum uric acid with bone mineral density and fragility fracture in patients with primary osteoporosis: a single-center retrospective study of 253 cases. Int J Clin Exp Med. 2015 Apr; 8(4): 6291–4. [PubMed]
20. Kaushal N, Vohora D, Jalali RK, Jha S. Raised serum uric acid is associated with higher bone mineral density in a cross-sectional study of a healthy Indian population. Ther Clin Risk Manag. 2018 Jan;14:75-82. [PubMed] [Crossref]
21. Lin KM, Lu CL, Hung KC, Wu PC, Pan CF, Wu CJ, et al. The Paradoxical Role of Uric Acid in Osteoporosis. Nutrients. 2019 Sep; 11(9): 2111. [PubMed] [Crossref]
22. Eun Y, Han KD, Kim DH, Kim IY, Park EJ, Lee S, et al. Association between anemia and hyperuricemia: results from the Korean National Health and Nutrition Examination Survey. Sci Rep. 2019 Dec; 9(1): 19067. [PubMed] [Crossref]

Received: 22 May 2019
Published online: 24 April 2020

back to Online Journal